The 2023 Alzheimer's Association International Conference (AAIC) in Amsterdam brought together the world's leading scientists, clinical researchers, early career investigators, caregiving researchers and more to discuss the latest findings and advancements in dementia science. Dr. Percy Griffin joins the podcast to share key highlights from the conference. He discusses the use of CRISPR technology in Alzheimer's research, the significance of defining Alzheimer's by its biology rather than its symptoms and how the field is moving toward a precision medicine approach.
Guest: Percy Griffin, PhD, director of scientific engagement, Alzheimer’s Association
Show NotesLearn more about the Wisconsin Alzheimer’s Disease Research Center’s Fall Community Conversation on our website, and watch the livestream on our YouTube page.
AAIC is the world’s largest forum dedicated to advancing dementia research. Find more highlights from the conference, including on-demand content that is available to watch through September 20, 2023, at 11:59 p.m. CT, on the AAIC website.
Find news highlights on CRISPR technology, county-level prevalence data on Alzheimer's, the ACHIEVE study and more mentioned by Dr. Griffin on the AAIC website.
Listen to our AAIC 2022 highlights episode with Dr. Griffin, mentioned at 1:15, on our website, Spotify, Apple Podcasts, YouTube, or wherever you listen.
Learn more about Dr. Griffin in his bio on the Alzheimer’s Association’s website.
Connect with usFind transcripts and more at our website.
Email Dementia Matters: dementiamatters@medicine.wisc.edu
Follow us on Facebook and Twitter.
Subscribe to the Wisconsin Alzheimer’s Disease Research Center’s e-newsletter.
Making an IMPACT: Advancing Alzheimer’s Disease Clinical Trials Through Workforce Development and Inclusivity
Living with Lewy Body: A Neurologist’s Journey Through Research and Dementia Care
The Fundamentals of Neuropsychology: Breaking Down Cognition, Memory and More
Long COVID and Its Effect on Cognition
Listen Up! The Connections Between Hearing Loss, Hearing Interventions and Cognitive Decline
From Caregiver to Research Participant: How One Woman’s Experience as a Dementia Caregiver Drew Her to Alzheimer’s Research
Looking at Lecanemab’s Eligibility Guidelines and Prescription Process
Do Non-Medicinal Interventions Reduce Dementia Risk? Studies are Inconclusive, Here’s Why
The Road to Hope: Philanthropy’s Impact on Alzheimer’s Research
Could Green Tea Hold the Key to New Alzheimer’s Treatments?
The Impact of Social Isolation on Dementia Risk in Older Adults
Memories and Milestones: Celebrating Six Years of ‘Dementia Matters’
Crosswords or Computers: Which is Better for Cognitive Engagement?
RAISE(ing) Support for Caregivers: State and National Resources for Family Care Partners
Mental Health and Memory: The Connections between Chronic Mental Illness and Dementia
A Fair Fight Against Alzheimer’s: The Need for Equity in Dementia Research and Care
Agitation and Alzheimer’s: Strategies for Managing Behavioral and Psychological Symptoms of Dementia
Promises to Practice: Creating Sustainable Community Partnerships to Support Alzheimer’s Research
Study Shows APOE Gene Affects Hispanic Populations’ Risk of Cognitive Decline Differently to Non-Hispanic Populations
Create your
podcast in
minutes
It is Free
Life in the A-Zone
Caregiver Storyteller - About Alzheimer’s and Dementia Caregiving
The Life, Love, and Alzheimer’s Podcast
Fading Memories: Alzheimer’s/Dementia Caregiver Support
Alzheimer’s Speaks